TABLE 1.
Study population characteristics (n=343)
| Characteristic | |
|---|---|
| Sex | |
| Male | 177 (51.6) |
| Female | 166 (48.4) |
| Ethnicity | |
| Aboriginal | 230 (67.1) |
| Caucasian | 79 (23.0) |
| Other | 12 (3.5) |
| Unknown | 22 (6.4) |
| Age at diagnosis, years | |
| <20 | 15 (4.4) |
| 20–29 | 108 (31.5) |
| 30–39 | 108 (31.5) |
| 40–49 | 80 (23.3) |
| ≥50 | 32 (9.3) |
| Year of diagnosis | |
| 2005 | 54 (15.7) |
| 2006 | 41 (12.0) |
| 2007 | 55 (16.0) |
| 2008 | 74 (21.6) |
| 2009 | 88 (25.7) |
| 2010 | 31 (9.0) |
| Site of care | |
| Positive Living Program | 187 (54.5) |
| Westside Community Clinic | 84 (24.5) |
| Both | 72 (21.0) |
| History of injection drug use | |
| Yes | 272 (79.3) |
| No | 64 (18.7) |
| Unknown | 7 (2.0) |
| Hepatitis C virus antibodies | |
| Present | 264 (77.0) |
| Absent | 70 (20.4) |
| Unknown | 9 (2.6) |
| Ever on antiretroviral therapy | |
| Yes | 167 (48.7) |
| No | 123 (35.9) |
| Unknown | 53 (15.5) |
| Baseline CD4 counts*, cells/μL | |
| <200 | 53 (15.5) |
| 200–349 | 74 (21.6) |
| ≥350 | 126 (36.7) |
| Unknown | 90 (26.2) |
| Immunological AIDS | |
| Yes | 132 (38.5) |
| No | 192 (56.0) |
| Unknown | 19 (5.5) |
| Deaths | 23 (6.7) |
| Age at diagnosis, years, mean ± SE | 35.1±0.6 |
| Baseline CD4 count*, cells/μL, mean ± SE | 382.1±14.4 |
| Baseline viral load log10, mean ± SE | 4.38±0.1 |
Data presented as n (%) unless otherwise specified.
*
Baseline defined as the first measure within six months of HIV diagnosis